Top 10 Blue Chip Stocks To Buy For 2017


European Pressphoto Agency

An upbeat reading on U.S. retail sales isnt enough to keep U.S. stock indices from tanking today. The Dow dropped more than 200points in late afternoon market action.

The Dow Jones Industrial Average dropped 1.19% and the S&P 500 fell 1% while the Nasdaq Composite fell 0.6%.

Energy and financial shares in the S&P 500 led the declines with the Energy Select Sector SPDR ETF (XLE) and the Financial Select Sector SPDR ETF (XLF) falling 1.5% and 1.3%respectively.


Stock indices have fluctuated severely this week. The Dow posted its biggest gain since March on Tuesday, only to record its worst fall since Feb. 11 the next day. As of now, the blue chip index is poised to record its third straight weekly loss.

Investors are facing a variety of overhangs, from cloudy expectations for corporate earnings to next months Federal Reserve meeting and the UK is poised to vote on whether to exit the European Union.

Top 10 Blue Chip Stocks To Buy For 2017: Palo Alto Networks, Inc.(PANW)


Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Palo Alto Networks (PANW) , Cisco Systems (CSCO) , Tanger Factory Outlet Centers (SKT) and Consolidated Edison (ED) .

  • [By Chris Lange]

    Palo Alto Networks Inc. (NYSE: PANW) is set to report its most recent results on Monday. The analysts consensus estimates call for earnings per share (EPS) of $0.53 and $400.2 million in revenue. Shares were changing hands at $161.35on Friday. The consensus price target is $180.89, and the 52-week trading range is $111.09 to $194.73.

  • [By Lisa Levin]

    Palo Alto Networks Inc (NYSE: PANW) was down, falling around 23 percent to $116.87. Palo Alto posted upbeat Q2 earnings, but sales missed expectations. The company also issued a weak forecast for the current quarter. JP Morgan downgraded Palo Alto from Overweight to Neutral, while Baird downgraded the stock from Outperform to Neutral.

  • [By WWW.THESTREET.COM]

    On Monday, Cramer said, he’ll be looking out for Tyson Foods (TSN) , Jack in the Box (JACK) and Palo Alto Networks (PANW) . Tyson is good, but out of favor, Cramer said while remaining bullish on Jack and Palo Alto.

  • [By Wayne Duggan]

    Trump recently appointed former New York mayor Rudy Giuliani as head of his cybersecurity task force. Trump has pledged to immediately initiate a review of “all U.S. cyber defenses and vulnerabilities, including critical infrastructure.” The review and response process could mean new government contracts on the way for cybersecurity stocks such as FireEye Inc (NASDAQ: FEYE) and Palo Alto Networks Inc (NYSE: PANW).

  • [By Harsh Chauhan]

    Palo Alto Networks (NYSE:PANW) will look for redemption when it releases its second-quarter fiscal 2017 results after the bell on Feb. 28. The network security specialist had offered a weaker-than-expected outlook in its last quarterly report as some of its deals requiring “additional approvals” got pushed back.

Top 10 Blue Chip Stocks To Buy For 2017: Oclaro, Inc.(OCLR)


Advisors’ Opinion:

  • [By Arie Goren]

    Advanced Micro Devices, Inc.(NSDQ:AMD)had been by far the best performer in 2016 among all the 413 Russell 3000 tech stocks. Its stock price appreciation of 295.1% in 2016 was significantly higher than the second ranked tech stock NVIDIA Corporation (NVIDIA (NSDQ:NVDA)which gained 223.8% and the third-ranked stock Oclaro Inc. (NSDQ:OCLR)which was up 157.2% in 2016.

Top 10 Blue Chip Stocks To Buy For 2017: Santander Consumer USA Holdings Inc.(SC)


Advisors’ Opinion:

  • [By Wayne Duggan]

    Height Financial Services analyst Edwin Groshans believes Credit Acceptance Corp, Santander Consumer USA Holdings Inc (NYSE: SC), Ally Financial Inc (NYSE: ALLY) and Capital One Financial Corp. (NYSE: COF).

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested going long on small cap consumer financestock Santander Consumer USA Holdings (NYSE: SC):

Top 10 Blue Chip Stocks To Buy For 2017: Blackrock Global(BOE)


Advisors’ Opinion:

  • [By Robert Rapier]

    Whiting Petroleum (WLL) is one of Continental’s biggest competitors in the Bakken. Whiting is the second-largest oil producer in North Dakota, averaging 82,500 barrels of oil equivalent (BOE) of production in 2012, across more than 700,000 acres of leased land.

Top 10 Blue Chip Stocks To Buy For 2017: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.


    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:


    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.


    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.


    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

Top 10 Blue Chip Stocks To Buy For 2017: Westar Energy, Inc.(WR)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Thursday, utilities shares rose by 0.02 percent. Top gainers in the sector included Westar Energy Inc (NYSE: WR), Westar Energy Inc (NYSE: AT), and NRG Energy Inc (NYSE: NRG).

  • [By Jayson Derrick]

    According to a report by Bloomberg, Westar Energy Inc (NYSE: WR) is a potential takeover target from rival Ameren Corp (NYSE: AEE) and a consortium of investors, including Toronto-based Borealis Infrastructure Management and the Canada Pension Plan Investment Board.

Top 10 Blue Chip Stocks To Buy For 2017: B&G Foods, Inc.(BGS)

Advisors’ Opinion:

  • [By Chris Lange]

    B&G Foods Inc. (NYSE: BGS) madewaves late on Friday after the company announced its most recent acquisition. B&G has now acquired Victoria Fine Foods from Huron Capital Partners and other sellers for roughly $70 million in cash.

Top 10 Blue Chip Stocks To Buy For 2017: Viking Therapeutics, Inc.(VKTX)


Advisors’ Opinion:

  • [By Lisa Levin]

    Viking Therapeutics Inc (NASDAQ: VKTX) shares dropped 39 percent to $1.17 after the company priced 7.5 million share offering at $1.25 per share.

Top 10 Blue Chip Stocks To Buy For 2017: Oshkosh Corporation(OSK)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Oshkosh (OSK) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $62 price target. The valuation is less attractive, as the stock is trading at 21x expected 2017 earnings, analysts said. 

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS). Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

  • [By Rich Smith]

      I first named Oshkosh my top stock pick back in September, when the stock cost $42 and change. Since then, the stock has gone down, and sells for $3 less. So am I supposed to dislike Oshkosh stock now?

    No. To the contrary, I like it even more. (About $3 more, in fact).

    You see, even in the process of picking Oshkosh back then, I warned investors: "I don’t know whether Oshkosh will be the best-performing stock in the world in the month of September, but I’ve got a strong hunch about the next six months." And that hunch remains — because the facts have not changed.


    This past summer, Oshkosh was named the winner of the Pentagon’s contract to build a next-gen "Humvee" — an armored Joint Light Tactical Vehicle that will serve the U.S. military for decades to come. Oshkosh won an initial award to produce 17,000 vehicles for $6.7 billion. Ultimately, though, this is a contract that could swell to $30 billion or more for production, maintenance, and upgrade of approximately 55,000 JLTVs across all military branches.

    So why hasn’t Oshkosh stock moved in response to the contract? Mainly because rival bidderLockheed Martin threw a monkey wrench into the contracts process, first protesting the JLTV award to Oshkosh, and then, when that protest was rejected, filing suit in court to try to win the contract away from its rival.


    Personally, I think Lockheed Martin will lose that suit as well. After all, Lockheed’s forte is in fighter jets, while Oshkosh is the military’s premier supplier of trucks like JLTV, as well as the Army’s M-ATV vehicle (a small, all-terrain MRAP). Perhaps recognizing this, AM General, the other company that bid against Oshkosh on JLTV and lost, declined to protest the award. Lockheed took the other road, but I expect it will be a dead end for Lockheed as well.

Top 10 Blue Chip Stocks To Buy For 2017: Helen of Troy Limited(HELE)

Advisors’ Opinion:

  • [By Teresa Rivas]

    Helen of Troy (HELE) is trading lower Friday, after reporting a mixed first quarter.

    The personal care products company said it earned $1.27 a share on revenue that rose 0.8% to $347.9 million. Analysts were expecting earnings of $1.17 per share on revenue of $356.1 million. Gross profit margin increased 2.3 percentage points to 43.8%, while cash flow from operations climbed from $37.8 million in the year ago period to $41.7 million.

    For the full year, Helen of Troy expects to earn between $5.85 to $6.35 a share on revenue of $1.57 billion to $1.62 billion. Analysts are modeling for earnings of $6.12 a share on revenue of $1.6 billion. However the company also warned that it expects a decline in sales for its nutritional supplement division.

    Jefferies Trevor Young reiterated a Buy rating and $114 price target on the stock today:

    Despite the 1Q revenue miss and ~30bps (~$4m) expected incremental FX headwinds, management maintained its FY revenue and adjusted EPS guidance (GAAP EPS came down $0.23 on the high and low end due to $6.6m of after tax non-cash asset impairment and patent litigation charges). Embedded in this guidance is the assumption of beauty coming in at the low end of the previous -7% to -12% range, and nutritional declining MSD (vs. flat to LSD positive growth previously). We believe this implies that housewares (MSD positive growth guidance previously) and health & home (LSD positive growth previously) would have to perform incrementally better than prior expectations, which we view as a positive.

    The shares are down 3.3% to $99.31 in recent trading.